Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT01708343
Other study ID # MPS-DIMS
Secondary ID
Status Recruiting
Phase Phase 3
First received October 9, 2012
Last updated October 15, 2012
Start date January 2011
Est. completion date November 2012

Study information

Verified date October 2012
Source Hospital de Clinicas de Porto Alegre
Contact WOLNEI CAUMO, MD, PhD
Phone 55-51-3359-8083
Email caumo@cpovo.net
Is FDA regulated No
Health authority Brazil: National Committee of Ethics in Research
Study type Interventional

Clinical Trial Summary

To test the hypothesis that the effect of either multiple deep intramuscular stimulation therapy [(DIMMST: trigger point deep dry needling (TrP-DDN) is combined with paraspinal deep intramuscular stimulation (PDIMS) and needle rotation (NR)] would be more effective than a placebo-sham for the treatment of MPS and that DIMMST would be more effective than LTrP-I for improving pain relief, sleep quality, and physical and mental state of the patient.


Recruitment information / eligibility

Status Recruiting
Enrollment 75
Est. completion date November 2012
Est. primary completion date November 2012
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 19 Years to 50 Years
Eligibility Inclusion criteria

- Myofascial pain syndrome (MPS) (defined as regional pain, normal neurologic examination, presence of TrPs, taut bands, tender points, and pain characterized as "dull," "achy," or "deep" were relevant to MPS diagnosis. Additionally, palpable nodules, pain that is exacerbated by stress, decreased range of motion, and ropiness in the muscle).

- Disability in the last three months: (defined if they had one or more these limitation in active and routine activities by MPS : (i) interference with work, (ii) enjoyable activities, (iii) responsibilities at home, (iv) relationships, (v) personal goals, (vi) thinking clearly, and problem solving, concentrating, or remembering during the last three months).

- Women

- Age: 19 to 50 years

Exclusion criteria

Rheumatoid arthritis

Fibromyalgia

Previous surgery on the affected areas

Prior experience with acupuncture

Primary radiculopathy

Current use of psychotropic drugs (ilicits

) Habitual use of anti-inflammatory steroids.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Procedure:
DIMMST


Locations

Country Name City State
Brazil Hospital de Clínicas de Porto Alegre Porto Alegre RS
Brazil Hospital de Clínicas de Porto Alegre Porto Alegre RS
Brazil Hospital de Clínicas E Porto Alegre Porto Alegre RS

Sponsors (1)

Lead Sponsor Collaborator
Hospital de Clinicas de Porto Alegre

Country where clinical trial is conducted

Brazil, 

Outcome

Type Measure Description Time frame Safety issue
Other Physical and mental Health Health-related quality of life, assessed at baseline and the end of treatment sessions, was measured with the SF-12 Summary Scales Before to begin treatment and after end treatment No
Primary Pain severity a) The intensity of pain was measured by a 10-cm VAS [30]. VAS scores ranged from no pain (zero) to the worst possible pain (10 cm). A cumulative mean of each week during the treatmetn period (four weeks - the pain diary begin in the first of treatment to the last session) Yes
Primary Pain threshold Pain pressure threshold (PPT) A cumulative mean of each week during the treatmetn period (four weeks - the pain diary begin in the first of treatment to the last session) Yes
Secondary Sleep quality - how did you feel when you woke up Sleep quality was recorded daily by the 10-cm visual analog sleep quality scale (VASQS) in the sleep diary using VASQS:
In general, how did you feel when you woke up?
A cumulative mean of each week during the treatmetn period (four weeks - the pain diary begin in the first of treatment to the last session) Yes
Secondary Sleep quality - compared to your habitual sleep Sleep quality was recorded daily by the 10-cm visual analog sleep quality scale (VASQS) in the sleep diary using VASQS:
Assess the sleep quality of the previous night compared to your habitual sleep?
A cumulative mean of each week during the treatmetn period (four weeks - the pain diary begin in the first of treatment to the last session) Yes
Secondary Sleep quality -last night Sleep quality was recorded daily by the 10-cm visual analog sleep quality scale (VASQS) in the sleep diary using VASQS:
How well did you sleep last night?
A cumulative mean of each week during the treatmetn period (four weeks - the pain diary begin in the first of treatment to the last session) Yes